US20040138537A1 - Solid-state non-invasive thermal cycling spectrometer - Google Patents
Solid-state non-invasive thermal cycling spectrometer Download PDFInfo
- Publication number
- US20040138537A1 US20040138537A1 US10/684,857 US68485703A US2004138537A1 US 20040138537 A1 US20040138537 A1 US 20040138537A1 US 68485703 A US68485703 A US 68485703A US 2004138537 A1 US2004138537 A1 US 2004138537A1
- Authority
- US
- United States
- Prior art keywords
- infrared
- window
- radiation detector
- temperature gradient
- cooling
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000005382 thermal cycling Methods 0.000 title description 2
- 230000005855 radiation Effects 0.000 claims abstract description 48
- 230000001939 inductive effect Effects 0.000 claims abstract description 20
- 239000010410 layer Substances 0.000 claims description 67
- 238000010438 heat treatment Methods 0.000 claims description 66
- 238000001816 cooling Methods 0.000 claims description 64
- 239000000463 material Substances 0.000 claims description 32
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 26
- 239000008103 glucose Substances 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 25
- 239000012491 analyte Substances 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 239000011241 protective layer Substances 0.000 claims description 16
- 230000003287 optical effect Effects 0.000 claims description 14
- 238000005259 measurement Methods 0.000 claims description 12
- 238000012545 processing Methods 0.000 claims description 12
- 230000005540 biological transmission Effects 0.000 claims description 9
- 239000012782 phase change material Substances 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 8
- 230000003595 spectral effect Effects 0.000 claims description 7
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 238000001514 detection method Methods 0.000 claims description 5
- 238000002329 infrared spectrum Methods 0.000 claims description 4
- 230000003667 anti-reflective effect Effects 0.000 claims description 3
- 238000004891 communication Methods 0.000 claims description 3
- 229910003460 diamond Inorganic materials 0.000 claims description 2
- 239000010432 diamond Substances 0.000 claims description 2
- 239000002210 silicon-based material Substances 0.000 claims 2
- 239000003575 carbonaceous material Substances 0.000 claims 1
- 238000009413 insulation Methods 0.000 claims 1
- 239000012212 insulator Substances 0.000 claims 1
- 238000001228 spectrum Methods 0.000 abstract description 7
- 230000001052 transient effect Effects 0.000 abstract description 4
- 238000013481 data capture Methods 0.000 abstract description 2
- 238000005070 sampling Methods 0.000 abstract description 2
- 238000010521 absorption reaction Methods 0.000 description 10
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 6
- 229910052710 silicon Inorganic materials 0.000 description 6
- 239000010703 silicon Substances 0.000 description 6
- 238000000862 absorption spectrum Methods 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 230000008859 change Effects 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000002452 interceptive effect Effects 0.000 description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000000151 deposition Methods 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 229910052732 germanium Inorganic materials 0.000 description 3
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 3
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- PFNQVRZLDWYSCW-UHFFFAOYSA-N (fluoren-9-ylideneamino) n-naphthalen-1-ylcarbamate Chemical compound C12=CC=CC=C2C2=CC=CC=C2C1=NOC(=O)NC1=CC=CC2=CC=CC=C12 PFNQVRZLDWYSCW-UHFFFAOYSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229920004779 ULTEM® 2300 Polymers 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000006117 anti-reflective coating Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 238000000295 emission spectrum Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 231100000647 material safety data sheet Toxicity 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000011253 protective coating Substances 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000003303 reheating Methods 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 239000002918 waste heat Substances 0.000 description 2
- JBRZTFJDHDCESZ-UHFFFAOYSA-N AsGa Chemical compound [As]#[Ga] JBRZTFJDHDCESZ-UHFFFAOYSA-N 0.000 description 1
- 229910001020 Au alloy Inorganic materials 0.000 description 1
- 230000005457 Black-body radiation Effects 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229910001218 Gallium arsenide Inorganic materials 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 235000011449 Rosa Nutrition 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- FGNOVNMCFCLRNZ-UHFFFAOYSA-N [Ge].[As].[Se] Chemical compound [Ge].[As].[Se] FGNOVNMCFCLRNZ-UHFFFAOYSA-N 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- DGJPPCSCQOIWCP-UHFFFAOYSA-N cadmium mercury Chemical compound [Cd].[Hg] DGJPPCSCQOIWCP-UHFFFAOYSA-N 0.000 description 1
- QHFQAJHNDKBRBO-UHFFFAOYSA-L calcium chloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2] QHFQAJHNDKBRBO-UHFFFAOYSA-L 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 239000012809 cooling fluid Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 238000002109 crystal growth method Methods 0.000 description 1
- 229910021419 crystalline silicon Inorganic materials 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000011213 glass-filled polymer Substances 0.000 description 1
- 102000035122 glycosylated proteins Human genes 0.000 description 1
- 108091005608 glycosylated proteins Proteins 0.000 description 1
- 239000003353 gold alloy Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000012666 negative regulation of transcription by glucose Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 238000002310 reflectometry Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 229940065287 selenium compound Drugs 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/01—Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1491—Heated applicators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/02—Details
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/02—Details
- G01J3/0286—Constructional arrangements for compensating for fluctuations caused by temperature, humidity or pressure, or using cooling or temperature stabilization of parts of the device; Controlling the atmosphere inside a spectrometer, e.g. vacuum
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/02—Details
- G01J3/0291—Housings; Spectrometer accessories; Spatial arrangement of elements, e.g. folded path arrangements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/28—Investigating the spectrum
- G01J3/42—Absorption spectrometry; Double beam spectrometry; Flicker spectrometry; Reflection spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J5/00—Radiation pyrometry, e.g. infrared or optical thermometry
- G01J5/02—Constructional details
- G01J5/06—Arrangements for eliminating effects of disturbing radiation; Arrangements for compensating changes in sensitivity
- G01J5/061—Arrangements for eliminating effects of disturbing radiation; Arrangements for compensating changes in sensitivity by controlling the temperature of the apparatus or parts thereof, e.g. using cooling means or thermostats
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01K—ELECTRIC INCANDESCENT LAMPS
- H01K7/00—Lamps for purposes other than general lighting
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
Definitions
- the present invention relates to an apparatus for inducing transient thermal gradients in human or animal tissue, and for obtaining infrared spectra from the tissue as the thermal gradient propagates through the tissue.
- the resulting infrared spectra may then be used to determine concentration of substances (analytes) present in the tissue, for example, glucose.
- Planck's Equation does not completely describe the sum total of all energy emitted by a human body. Variations from perfect agreement with Planck's Equation are caused by selective absorption of radiation by the layers of tissue and body fluid in the human body. Thus, layers of tissue and blood or other fluids may selectively absorb emitted energy from the deeper layers of the body before that energy can reach the surface of the skin. Furthermore, because the deeper layers of the human body are warmer than the outer layers, a temperature gradient exists within the body. This causes a further deviation from theoretical black body radiation emission.
- composition-dependent absorption spectra may be constructed from proper analysis of the total energy emitted from the body.
- the composition of matter may be depth dependent and, conversely, absorption spectra generated from deeper layers may contain sufficient composition information to allow accurate determinations of concentration of the individual constituents present in the tissue. This is possible when a temperature gradient either occurs naturally, or is induced in the body.
- an additional technique for determining the concentration of substances (“analytes”) in a tissue sample is set forth in U.S. patent application Ser. No. 09/267,121 ('121).
- the '121 application describes a method of measuring infrared emission emitted by a tissue sample subject to a temperature gradient. By detecting emitted signals at selected wavelengths and comparing them to carefully selected reference signals, a frequency or a magnitude or a phase difference between the reference signal and an analytical signal may be used to determine analyte concentration.
- the method taught in the '121 application teaches the use of an intermittently or periodically modulated temperature gradient and the continuing measurement of frequency, magnitude, or phase differences caused by analyte absorbance to determine analyte concentration.
- the '121 application teaches a method of correcting for the effects caused by tissue surfaces.
- a spectrometer for the non-invasive generation and capture of thermal gradient spectra from human or animal tissue.
- the '378 spectrometer includes an infrared transmissive thermal mass for inducing a transient temperature gradient in the tissue by means of conductive heat transfer with the tissue, and a cooling means in operative combination with the thermal mass for cooling this thermal mass.
- an infrared sensor for detecting infrared emissions emanating from the observed tissue as the gradient progresses into the tissue.
- a data capture means for sampling the output signals received from the sensor as the gradient progresses into the tissue.
- the '723 invention uses a cooled germanium cylinder brought into intermittent contact with the test subject's tissue.
- the resulting gradients are used to perform the methodology taught in Application '378.
- Skin rewarming is accomplished by simply allowing the patient's skin to naturally rewarm after each cooling contact Alternatively, rewarming may be accomplished by an external heat source in the form of a second warmer germanium cylinder.
- U.S. patent application Ser. No. 09/265,195 ('195) provides a “solid-state” apparatus for creating and measuring the effects of transient thermal gradients on tissue.
- the '195 application teaches a single thermal mass structure (“a thermal mass window”) which both heats and cools the tissue and is capable of transmitting the absorption spectra generated by the gradient. This allows the window to remain in contact with the tissue during the entire time measurements are made, thereby improving accuracy and measurement repeatability.
- a thermal mass window which both heats and cools the tissue and is capable of transmitting the absorption spectra generated by the gradient. This allows the window to remain in contact with the tissue during the entire time measurements are made, thereby improving accuracy and measurement repeatability.
- cycle time a fairly rapid cooling/rewarming cycle time
- Cycle times on the order of 2 Hz are preferred.
- Existing devices encountered some difficulties obtaining the requisite cycle times due to residual heat or cooling remaining in the thermal mass structures after heating and cooling steps. Thus, it took excessive time and energy to cyclically induce the cooling and heating steps.
- thermal gradient device that can induce temperature gradients more quickly and using less energy.
- An advantage of devices which generate gradients using less energy is that smaller devices may be constructed.
- a solid-state device for determining analyte concentrations within sample tissues.
- the device generates a thermal gradient in the tissue and measures infrared radiation spectra to make determinations of tissue analyte concentration.
- the device comprises an infrared transmissive window assembly having a plurality of infrared transmissive elements, one of which being a heating element, another being an insulating element.
- the device also has a cooling element in operative combination with the insulating element.
- the device also comprises an infrared detector for detecting an infrared radiation spectrum as it passes through said window assembly.
- An important aspect of the invention is a thermal insulating and impedance matching element positioned between the heating and cooling elements.
- Yet another embodiment of the invention enhances the ability of the device to rapidly cycle through the cooling/rewarming cycle by including a heat sink in thermal contact with the cooling element. This effectively stabilizes the temperature in the device during cycling. This heat stability is enhanced through the use of a phase change material.
- FIG. 1 is a schematic depiction of an apparatus constructed in accordance with the principles of the present invention
- FIG. 2 is a cross-sectional view of a layered window assembly of the present invention
- FIG. 3 is an exploded cross-sectional view of the layered window assembly of FIG. 2 ;
- FIG. 4 is a plan view of a heater grid of the present invention.
- FIG. 5 is a cut-away perspective view of an apparatus illustrating the principles of the present invention.
- FIG. 6 is a graph of a temperature stability curve
- FIG. 7 is an exploded perspective view of a detector element of the present invention.
- the present invention relates to the measurement of infrared (IR) radiation emitted by heterogenous bodies.
- IR infrared
- an apparatus for inducing a temperature gradient in a tissue sample and measuring the IR radiation spectra emitted from the tissue is provided in the context of a particular application and its requirements.
- Various modifications to the preferred embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments.
- the present invention is not intended to be limited to the embodiments shown, but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
- the present invention teaches a method and apparatus for creating and controlling the magnitude, propagation, velocity, and contour profile of a thermal gradient, and incorporates cyclic cooling and rewarming of a sample observation site. Furthermore, the present invention teaches the detection and measurement of infrared spectral emissions from the sample tissues.
- FIG. 1 a block diagram of an embodiment of the present invention is shown.
- the embodiment shown provides a solid-state thermal gradient inducing device 500 for inducing a temperature gradient within a tissue sample 100 .
- the infrared emissions from the body are then transmitted through the thermal gradient device 500 where they are collected by an infrared radiation detector assembly 700 .
- the detector assembly 700 receives the infrared emissions from the tissue 100 and measures certain wavelength information which is passed on to a signal processing system 800 which processes the information.
- the several elements of the system will be described below.
- the solid-state thermal gradient device 500 is comprised of three general components: An infrared transmissive window assembly 200 which provides direct contact with a tissue sample 100 permitting the transmission of infrared radiation from the tissue sample to the IR radiation detector assembly 700 .
- the solid-state thermal gradient device 500 also includes a means 300 for inducing a temperature gradient in the tissue sample 100 .
- This means 300 typically includes a heating element and a cooling element.
- the heating element may be integral to the infrared transmissive window assembly 200 .
- the solid-state thermal gradient device 500 incorporates a heat sink 400 which is in thermal communication with the cooling element.
- the solid-state thermal gradient device 500 includes an infrared transmissive window assembly 200 .
- the window assembly 200 includes a plurality of infrared transmissive elements which may be constructed in a layered fashion.
- FIG. 3 depicts a layered window assembly 200 .
- the window assembly features an infrared transmissive thermally conductive spreader layer 205 .
- Underlying the spreader layer 205 is a heater or heating element 220 .
- This heating element 220 can be treated with a thin electrically insulating layer (not shown).
- Adjacent to the heating element 220 is a thermal insulating and impedance matching element 230 .
- Adjacent to the thermal insulating element 230 is a thermally conductive base layer 240 .
- the thermally conductive spreader layer 205 is coated on its top surface with a thin layer of protective coating 201 .
- the bottom surface of the base layer is coated with a thin overcoat layer 242 .
- protective coating 201 and overcoat layer 242 have antireflective properties.
- the spreader layer 205 is preferably formed of infrared transmissive material having a high thermal conductivity sufficient to facilitate heat transfer from the heater element 220 uniformly into the tissue sample 100 .
- a satisfactory material is silicon crystal formed using a float zone crystal growth method. A generalized discussion of this method of silicon fabrication may be found in Microchip Fabrication, A Practical Guide to Semiconductor Processing. 3 rd Ed., Peter Van Zant, McGraw Hill 1997, which is hereby incorporated by reference.
- Other effective materials include, but are not limited to, chemical vapor deposited diamond, diamondlike carbon, gallium arsenide, germanium, and other IR transmissive materials having sufficiently high thermal conductivity.
- Preferred dimensions for the spreader layer 205 are about one inch in diameter and about 0.010 of an inch thick.
- FIG. 3 shows a preferred embodiment of the spreader layer 205 with a beveled edge. Although not required, an approximate 45° bevel is preferred.
- a protective layer 201 is formed on the top surface of the spreader layer 205 .
- the protective layer is intended to protect the top surface of the spreader layer 205 from damage.
- the protective layer is highly resistant to mechanical damage, such as scratching and other abrasive forces.
- the protective layer is infrared transmissive. It is particularly advantageous if the protective layer 201 is also optimized to have antireflective properties and to increase transmission of optical radiation in the wavelength range of about 5 to 12 ⁇ . For example, when a float zone silicon is used as a spreader layer 205 , the spreader layer reflects 30% of the incident light at the air:silicon interface because of the relatively high refractive index of silicon.
- the protective layer 201 is designed to match the refractive index of tissue and reduce the surface reflectance of the spreader layer 205 , thereby optimizing the amount of energy passing through the window assembly 200 .
- the protective layer 201 must also have high thermal conductivity.
- a satisfactory protective layer material is a proprietary multi-layer Broad Band Anti-Reflective Coating produced by Deposition Research Laboratories, Inc. of St. Charles, Mo. Diamondlike carbon coatings are also satisfactory.
- a heating element 220 Underlying the spreader layer 205 is a heating element 220 .
- the heating element 220 must also provide a maximum acceptable optical throughput and should be electrically insulated from the spreader layer substrate material.
- a preferred heating element 220 obscures about 10% or less of the window assembly 200 .
- Satisfactory heating elements include, but are not limited to, heat exchangers, electrical resistance heating grids, thermal electric heaters, radio frequency (RF) heaters, infrared radiation heaters, optical heaters, or wire bridge heating grids.
- RF radio frequency
- a doped infrared transmissive material with regions of higher and lower resistivity may be used.
- a doped silicon layer may be used as a heater.
- FIG. 4 shows a metal heater grid 221 designed and manufactured by Deposition Research Laboratories, Inc.
- the heater grid 221 has a resistance of about 2 ohms and has a preferred thickness of 1,500 ⁇ .
- a preferred grid material is a gold alloy, but other acceptable materials include, but are not limited to, platinum (Pt), titanium (Ti), tungsten (W), copper (Cu), and nickel (Ni).
- the perimeter of the grid is surrounded by a bus bar 222 for contacting electrode leads.
- the heater 220 is covered with an electrically insulating coating which also enhances adhesion to the spreader layer 205 .
- One preferred covering is an aluminum oxide (Al 2 O 3 ) coating over the grid pattern to prevent electrical current from conducting through the spreader layer 205 into the tissue 100 .
- Al 2 O 3 also advantageously increases the adhesion of the heater element 220 to the spreader layer 205 .
- Other acceptable materials include, but are not limited to, titanium dioxide (TiO 2 ) or zinc selenide (ZnSe).
- the heater grid 221 is electrically connected to an electrical power source through the bus 222 .
- a preferred bus bar material is gold.
- One preferred example of a heater grid incorporates a variable pitch distance “d” between the conducting lines to maintain a constant power density across the entire grid 221 . In this embodiment a preferred line width “w” is about 25 microns.
- Another design for maintaining a constant power density across the entire grid 221 incorporates varying line widths “w” while keeping the pitch distance “d” constant.
- the thermal insulating layer 230 serves several novel and surprising functions which will be discussed in more detail below.
- the thermal insulating layer 230 prevents the dissipation of heat from the heater element 220 while allowing the cold from a cooling element (not shown) to effectively cool the tissue 100 .
- the thermal insulating layer 230 is comprised of a material having thermally insulative (e.g., lower thermal conductivity than the spreader layer) and infrared transmissive qualities.
- a preferred material is a germanium arsenic selenium compound of the calcogenide glass family known as AMTIR-1 produced by Amorphous Materials, Inc.
- the pictured embodiment has a diameter of about 0.85 of an inch and a preferred thickness in the range of about 0.005 to about 0.010 of an inch.
- the thermal insulating layer 230 (having a low thermal conductivity) insulates this heat.
- a base layer 240 which is formed of thermally conducting material.
- a preferred material is crystalline silicon formed using float zone crystal growth. The purpose of this base layer 240 is to serve as a cold-conducting mechanical base for the entire layered window assembly.
- the bottom surface of the base layer is treated with an overcoat layer 242 .
- the overcoat layer 242 is preferably a proprietary multi-layer Broad Band Anti-Reflective Coating optimized for the transmission of radiation in the wavelength range between about 5 to about 12 ⁇ and having the refractive index of air. Such coating materials are available from Deposition Research Laboratories, Inc. in St. Charles, Mo.
- the overall optical transmission of the layered window assembly 200 is equal to or greater than 70%.
- the layered window assembly 200 is held together and secured to the gradient device 500 by a holding bracket.
- the bracket is preferably formed of a glass-filled plastic, for example, Ultem 2300, manufactured by General Electric.
- Ultem 2300 has a low thermal conductivity which insulates the heat transfer from the layered window assembly 200 .
- the tissue 100 is solely heated and cooled by the heat and cold emanating from the layered window assembly 200 .
- the layered window assembly 200 is depicted as resting above a cold reservoir 330 which is adjacent to the cooling element 350 .
- the cooling element 350 may be selected from such elements as air cooled convection coolers, passive conduction coolers, such as heat sinks, or active conduction coolers, such as, thermal electric coolers.
- the cooling element 350 may be also selected from the group of cooling elements including, but not limited to, water baths, gas coolers using cold N 2 or other gases, or infrared transmissive cooling fluids.
- the preferred cooling element is a thermal electric cooler, for example, a 25 W thermal electric cooler manufactured by Melcor in Trenton, N.J.
- the cooling element 350 (hereinafter referred to as “thermal electric cooler” or “TEC”) is positioned in thermal contact with the cold reservoir 330 .
- a preferred cold reservoir 330 is a copper ring structure which is in thermal contact with both the layered window assembly 220 and the TEC 350 .
- the heating element 220 it is the combination of the heating element 220 , the thermal insulating element 230 , the cold reservoir 330 , and the cooling element 350 that comprises a means for inducing a temperature gradient in the tissue 100 .
- this is accomplished by setting the cooling element 350 to a constant temperature of in the range of about 8-15° C.
- the heating element 220 is then cyclically activated to heat to a maximum of about 40° C. Thermal cycling the heating element 220 cyclically heats the layered window assembly 200 and induces a temperature gradient in the tissue 100 .
- a thermal electric cooler is chosen as the cooling element 350 .
- a heat sink 400 is in thermal communication with the TEC 350 .
- the heat sink 400 effectively bleeds off the waste heat from the TEC 350 , enabling the device 500 to function within a constant temperature range.
- the heat sink may have cooling fins 410 to enhance the cooling effectiveness of the heat sink 400 .
- the heat sink 400 features a cavity 420 .
- the cavity may be filled with a phase change material 430 (not shown) to enhance the temperature stabilizing effect of the heat sink 400 .
- a phase change material 430 as defined herein is any material which undergoes a temperature dependent change of phase. For example, water undergoes a phase change from ice to water. In the process of undergoing the phase change, such materials absorb a great deal of heat, thereby enhancing the effectiveness of the heat sink 400 .
- a preferred phase change material 430 is a hydrated salt, such as calcium chloride hexahydrate.
- TH29 is produced by Phase Change Solutions, of Naperville, Ill. Further description of this material is included in that firm's MSDS which is incorporated by reference. This material has a melting point of 29° C., which is close to the working temperature of the device.
- FIG. 6, is a graph of temperature stability over time with the instrument operating normally.
- the temperature stability, over time, of a heat sink using TH29 610 has superior temperature stability performance than both water 620 and a heat sink 400 with no phase change material 630 .
- the ability of the gradient inducing means is further enhanced by the presence of the thermal insulating layer 230 of the layered window assembly 200 .
- the thermal insulating layer 230 is positioned between the heating element 220 and the base 240 . It was discovered by the inventors that, in the absence of the insulating element 230 , the cold from the cooling element 350 excessively reduced the temperature of the heating element 220 . This led to difficulties in reheating. In order to sufficiently rewarm the heating element 220 after such cooling, a great deal of power was required. Furthermore, the time required to heat the cooling element 350 to operational temperature prohibitively restricted the cycle time. Therefore, in an effort to increase the rate of heating and cooling and increase cycle time, a thermally insulating element 230 was added.
- the presence of the insulating element 230 helps the heating element 220 to maintain a consistent and relatively high temperature, thereby making it possible to reheat the heating element 220 and spreader layer 205 and, consequently, the tissue 100 more quickly.
- the insulating element makes reheating possible using less power. These factors make quicker cycle times possible.
- the surprising result is that the presence of the insulating layer 230 does not significantly inhibit the cooling effects of the TEC 350 . Therefore, the gradient inducing means (i.e. the heating element 220 , the thermally insulating element 230 , and the cooling element 350 ) are substantially enhanced in their effectiveness by the presence of the thermally insulating layer 230 .
- the layered window assembly 200 is designed with the idea of transmitting the maximum amount of optical energy through the window 200 . Furthermore, the cold reservoir 330 , the thermal cooling element 350 , and heat sink 400 are all designed to minimally obstruct the transmission of optical radiation. Positioned beneath the layered window assembly 200 is an infrared radiation detector assembly 700 .
- infrared radiation detector 720 which forms a part of the infrared radiation detector assembly 700 . It should be pointed out that many different types of radiation detectors may be utilized including, but not limited to, interferometers, spectrophotometers, grating monochromators, variable filter monochromators, and groups of discrete infrared bandpass filters (or Fabry-Perot filters, including tunable Fabry-Perot filters) and detectors.
- the effectiveness of said infrared radiation detector assembly 700 may be enhanced by the presence of a high reflectance scrambler 710 .
- the scrambler 710 is designed to randomize the directionality of radiation which enters the layered window assembly 200 .
- the scrambler 710 effectively minimizes the effect of tissue irregularities thereby maximizing the detectable signal.
- the scrambler 710 is either made from, or coated with, a material which does not preferentially absorb optical radiation in the range of about 5 ⁇ to about 12 ⁇ .
- a satisfactory scrambler 710 may be constructed having an electroform gold layer.
- a satisfactory high reflectivity gold electroform optical scrambler 710 is manufactured by Epner Technology, of Brooklyn, N.Y.
- At the exit of the scrambler 712 lies a detector element 720 .
- the detector element 720 may be selected from among many suitable devices.
- One preferred embodiment uses a series of bandpass filters 720 F having an underlying series of radiation detectors 720 D.
- One embodiment uses several bandpass wavelengths optimized to detect the presence of a glucose analyte in a tissue sample.
- Glucose has several strong and distinguishing absorption peaks between 9 and 10 microns; meaning the transmission of optical energy through glucose drops significantly in this wavelength range.
- the infrared energy naturally emitted by the inner tissue passes through the glucose in the outer layers of the tissue, some of the energy in the 9.3 micron and 9.6 micron bands is absorbed.
- the human body is comprised mostly of water, it is necessary to differentiate the smaller amount of glucose present in the larger concentration of water in the human body.
- Water absorbs far- and mid-wavelength infrared energy at most wavelengths.
- an infrared transmission “window” exists in water, in which infrared energy is not completely absorbed. This “window” allows analysis of the 9.3 and 9.6 micron glucose absorption bands because this region of substantially reduced water absorption is the same region in which glucose strongly absorbs.
- this wavelength range may also provide reference wavelengths for both water and glucose, allowing their quantification.
- the wavelength ranges where water strongly absorbs can be used to determine the absorbance of the target tissue and, therefore, the surface radiation.
- wavelengths in the range of about 5.9-6.2 microns may be used to quantify water.
- strong and distinct water absorption peaks exist, providing ideal wavelengths for analyzing the tissue surface temperature.
- Different filter combinations can be optimized to detect other interfering analytes as well.
- other materials may be compensated for.
- interfering substances include, but are not limited to, Vitamin C, acetaminophen, alcohol, and urea.
- One preferred embodiment, optimized to detect the presence of a glucose analyte in a tissue sample uses eight filters 720 F having the following bandpass center wavelengths: 6.1 ⁇ , 6.9 ⁇ , 8.5 ⁇ , 9.3 ⁇ , 9.7 ⁇ , 10.4 ⁇ , 11.0 ⁇ , and 12.5 ⁇ . Filter combinations using a greater or a fewer number or different filters may be used. Satisfactory filters may be obtained from Optical Coating Laboratory, Inc. (OCLI) of Santa Rosa, Calif. It is contemplated that in accordance with the principles of the present invention, other filters or filter combinations optimized to detect other analytes may be used. Also, other detection methods or devices are contemplated by the present invention.
- the filtered radiation can be detected by a plurality of detectors 720 D, for example, an array of Photo Voltiac Mercury Cadmium Tellerium (PVMCT) detectors. Satisfactory detectors may be obtained from FERMIONICS of Simi Valley, Calif., for example, PV-9.1 detectors with PVA-481-1 preamplifiers may be used. Additionally, room temperature micro-bolometers can be used. These detectors produce an electronic signal which is passed on to a signal processing system 800 . Custom circuit boards produced by Optiscan may be used to control temperatures of the detector and the infrared transmissive window assembly. Similar units available from other manufacturers may also be used.
- PVMCT Photo Voltiac Mercury Cadmium Tellerium
- a satisfactory signal processing system 800 is a general purpose programmable personal computer commonly available from companies such as an IBM, Dell, Gateway, etc. Numerous other computers or data processing devices may be used with equal facility. Furthermore, a specialized computer, implemented as hardware, firmware, software or a combination thereof could be devised to accomplish the needed signal processing functions.
- the computer provides a computational engine, display and user interface.
- An analog-to-digital (A/D) system may be used to convert analog detector signals to appropriate computer input signals.
- an acceptable A/D converter is a “PCI-MIO-16XE10” manufactured by National Instruments of Austin, Tex.
- phase change materials may be used in conjunction with the heat sink as can many different layered window assemblies.
- bandpass filters are used in conjunction with the infrared detector, many different filters may be used and said filters may be optimized to detect analytes other than glucose.
Abstract
Description
- This application claims priority to and is a continuation-in-part of the co-pending application filed on Mar. 10, 1999, entitled “Solid-State Non-Invasive Infrared Absorption Spectrometer for the Generation and Capture of Thermal Gradient Spectra from Living Tissue”, identified by U.S. patent Ser. No. 09/265,195.
- The present invention relates to an apparatus for inducing transient thermal gradients in human or animal tissue, and for obtaining infrared spectra from the tissue as the thermal gradient propagates through the tissue. The resulting infrared spectra may then be used to determine concentration of substances (analytes) present in the tissue, for example, glucose.
- Millions of diabetics draw blood daily to determine blood glucose levels. Substantial effort has been expended in a search for a non-invasive method of accurately determining blood glucose concentrations. To that end, Optiscan Biomedical Corporation of Alameda, Calif., has significantly advanced the state of the art of non-invasive blood glucose analysis. In a series of patents and patent applications, Optiscan has defined the state of the art for non-invasive blood glucose determination.
- The methodologies taught in U.S. patent application Ser. Nos. 08/820,378 and 09/267,121 may be performed by the apparatuses taught in U.S. patent application Ser. Nos. 08/816,723 and 09/265,195, and each of these references is hereby incorporated by reference.
- By way of introduction, objects at temperatures greater than −273.16° C. (absolute zero) emit infrared energy. Such emissions are often described by Planck's Equation and referred to as “black body curves”. Theoretically, a body having an emissivity of 1.0 shows perfect agreement with Planck's Equation. Advantageously, many objects have emissivity close to 1.0. In particular, human tissue has emissivity of approximately 0.9 to 0.98. It is well known that infrared emissions from the human body may be closely approximated by Planck's Equation and yield black body type emission spectra.
- Although the human body emits energy having a distribution that approximates that described by Planck's Equation, Planck's Equation does not completely describe the sum total of all energy emitted by a human body. Variations from perfect agreement with Planck's Equation are caused by selective absorption of radiation by the layers of tissue and body fluid in the human body. Thus, layers of tissue and blood or other fluids may selectively absorb emitted energy from the deeper layers of the body before that energy can reach the surface of the skin. Furthermore, because the deeper layers of the human body are warmer than the outer layers, a temperature gradient exists within the body. This causes a further deviation from theoretical black body radiation emission.
- However, the inventors have determined that, when the above two conditions exist, a composition-dependent absorption spectra may be constructed from proper analysis of the total energy emitted from the body. For heterogeneous bodies, the composition of matter may be depth dependent and, conversely, absorption spectra generated from deeper layers may contain sufficient composition information to allow accurate determinations of concentration of the individual constituents present in the tissue. This is possible when a temperature gradient either occurs naturally, or is induced in the body.
- The invention taught in U.S. patent application Ser. No. 08/820,378 ('378) uses the naturally occurring body temperature as the source of infrared emissions. As these infrared emissions, which have emanated from deeper inside the body, pass through layers of tissue that are closer to the surface, certain wavelengths of energy are selectively absorbed by the intervening tissue. This selective absorption of signal produces bands of reduced energy in the expected emission spectra when the energy finally exits the material under study. This spectra is referred to as the absorption spectra of the material.
- The invention taught in patent application Ser. No. 08/816,723 ('723) uses actively induced cooling to promote the selective absorption of radiation by causing a temperature gradient to propagate to selected layers of tissue, which typically range between 40 and 250μ below the tissue surface. As explained in the '723 application, absorption spectra of the tissue may be measured and the determination of glucose concentration may be made.
- An additional technique for determining the concentration of substances (“analytes”) in a tissue sample is set forth in U.S. patent application Ser. No. 09/267,121 ('121). The '121 application describes a method of measuring infrared emission emitted by a tissue sample subject to a temperature gradient. By detecting emitted signals at selected wavelengths and comparing them to carefully selected reference signals, a frequency or a magnitude or a phase difference between the reference signal and an analytical signal may be used to determine analyte concentration. Furthermore, the method taught in the '121 application teaches the use of an intermittently or periodically modulated temperature gradient and the continuing measurement of frequency, magnitude, or phase differences caused by analyte absorbance to determine analyte concentration. Furthermore, the '121 application teaches a method of correcting for the effects caused by tissue surfaces.
- According to U.S. patent application Ser. No. 08/820,378 ('378), there is provided a spectrometer for the non-invasive generation and capture of thermal gradient spectra from human or animal tissue. The '378 spectrometer includes an infrared transmissive thermal mass for inducing a transient temperature gradient in the tissue by means of conductive heat transfer with the tissue, and a cooling means in operative combination with the thermal mass for cooling this thermal mass. There is also provided an infrared sensor for detecting infrared emissions emanating from the observed tissue as the gradient progresses into the tissue. Also included is a data capture means for sampling the output signals received from the sensor as the gradient progresses into the tissue. The '723 invention uses a cooled germanium cylinder brought into intermittent contact with the test subject's tissue. The resulting gradients are used to perform the methodology taught in Application '378. Skin rewarming, according to this invention, is accomplished by simply allowing the patient's skin to naturally rewarm after each cooling contact Alternatively, rewarming may be accomplished by an external heat source in the form of a second warmer germanium cylinder. U.S. patent application Ser. No. 09/265,195 ('195) provides a “solid-state” apparatus for creating and measuring the effects of transient thermal gradients on tissue. The '195 application teaches a single thermal mass structure (“a thermal mass window”) which both heats and cools the tissue and is capable of transmitting the absorption spectra generated by the gradient. This allows the window to remain in contact with the tissue during the entire time measurements are made, thereby improving accuracy and measurement repeatability.
- The inventors discovered that by inducing a cyclic temperature gradient certain measurement advantages accrue. These advantages are more apparent when a fairly rapid cooling/rewarming cycle time (hereinafter referred to as “cycle time”) is used. Cycle times on the order of 2 Hz are preferred. Existing devices encountered some difficulties obtaining the requisite cycle times due to residual heat or cooling remaining in the thermal mass structures after heating and cooling steps. Thus, it took excessive time and energy to cyclically induce the cooling and heating steps. There is a need for a thermal gradient device that can induce temperature gradients more quickly and using less energy. An advantage of devices which generate gradients using less energy is that smaller devices may be constructed.
- According to the principles of the present invention there is provided a solid-state device for determining analyte concentrations within sample tissues. The device generates a thermal gradient in the tissue and measures infrared radiation spectra to make determinations of tissue analyte concentration. The device comprises an infrared transmissive window assembly having a plurality of infrared transmissive elements, one of which being a heating element, another being an insulating element. The device also has a cooling element in operative combination with the insulating element. The device also comprises an infrared detector for detecting an infrared radiation spectrum as it passes through said window assembly.
- An important aspect of the invention is a thermal insulating and impedance matching element positioned between the heating and cooling elements. Yet another embodiment of the invention enhances the ability of the device to rapidly cycle through the cooling/rewarming cycle by including a heat sink in thermal contact with the cooling element. This effectively stabilizes the temperature in the device during cycling. This heat stability is enhanced through the use of a phase change material.
- Other features of the invention are disclosed or apparent in the section entitled “DETAILED DESCRIPTION OF THE INVENTION”.
- For a more comprehensive understanding of the present invention, reference is made to the accompanying drawings in the following Detailed Description of the Invention. In the drawings:
- FIG. 1 is a schematic depiction of an apparatus constructed in accordance with the principles of the present invention;
- FIG. 2 is a cross-sectional view of a layered window assembly of the present invention;
- FIG. 3 is an exploded cross-sectional view of the layered window assembly of FIG.2;
- FIG. 4 is a plan view of a heater grid of the present invention;
- FIG. 5 is a cut-away perspective view of an apparatus illustrating the principles of the present invention;
- FIG. 6 is a graph of a temperature stability curve;
- FIG. 7 is an exploded perspective view of a detector element of the present invention.
- Reference numbers refer to the same or equivalent parts of the invention throughout the several figures of the drawings.
- The present invention relates to the measurement of infrared (IR) radiation emitted by heterogenous bodies. In particular, an apparatus for inducing a temperature gradient in a tissue sample and measuring the IR radiation spectra emitted from the tissue. The following description is presented to enable one of ordinary skill in the art to make and use the invention as provided in the context of a particular application and its requirements. Various modifications to the preferred embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments. The present invention is not intended to be limited to the embodiments shown, but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
- A discussion of the principles of non-invasive infrared spectrometry applied to analyte quantification can be found in the incorporated references.
- The present invention teaches a method and apparatus for creating and controlling the magnitude, propagation, velocity, and contour profile of a thermal gradient, and incorporates cyclic cooling and rewarming of a sample observation site. Furthermore, the present invention teaches the detection and measurement of infrared spectral emissions from the sample tissues.
- Referring to FIG. 1, a block diagram of an embodiment of the present invention is shown. The embodiment shown provides a solid-state thermal
gradient inducing device 500 for inducing a temperature gradient within atissue sample 100. The infrared emissions from the body are then transmitted through thethermal gradient device 500 where they are collected by an infraredradiation detector assembly 700. Thedetector assembly 700 receives the infrared emissions from thetissue 100 and measures certain wavelength information which is passed on to asignal processing system 800 which processes the information. The several elements of the system will be described below. - The solid-state
thermal gradient device 500 is comprised of three general components: An infraredtransmissive window assembly 200 which provides direct contact with atissue sample 100 permitting the transmission of infrared radiation from the tissue sample to the IRradiation detector assembly 700. The solid-statethermal gradient device 500 also includes ameans 300 for inducing a temperature gradient in thetissue sample 100. This means 300 typically includes a heating element and a cooling element. The heating element may be integral to the infraredtransmissive window assembly 200. Finally, the solid-statethermal gradient device 500 incorporates aheat sink 400 which is in thermal communication with the cooling element. -
Window Assembly 200 - In one preferred embodiment of the present invention, as shown in FIG. 2, the solid-state
thermal gradient device 500 includes an infraredtransmissive window assembly 200. Thewindow assembly 200 includes a plurality of infrared transmissive elements which may be constructed in a layered fashion. - FIG. 3 depicts a
layered window assembly 200. The window assembly features an infrared transmissive thermally conductive spreader layer 205. Underlying the spreader layer 205 is a heater orheating element 220. Thisheating element 220 can be treated with a thin electrically insulating layer (not shown). Adjacent to theheating element 220 is a thermal insulating and impedance matching element 230. Adjacent to the thermal insulating element 230 is a thermally conductive base layer 240. The thermally conductive spreader layer 205 is coated on its top surface with a thin layer of protective coating 201. The bottom surface of the base layer is coated with a thin overcoat layer 242. Preferably, protective coating 201 and overcoat layer 242 have antireflective properties. - The spreader layer205 is preferably formed of infrared transmissive material having a high thermal conductivity sufficient to facilitate heat transfer from the
heater element 220 uniformly into thetissue sample 100. A satisfactory material is silicon crystal formed using a float zone crystal growth method. A generalized discussion of this method of silicon fabrication may be found in Microchip Fabrication, A Practical Guide to Semiconductor Processing. 3rd Ed., Peter Van Zant, McGraw Hill 1997, which is hereby incorporated by reference. Other effective materials include, but are not limited to, chemical vapor deposited diamond, diamondlike carbon, gallium arsenide, germanium, and other IR transmissive materials having sufficiently high thermal conductivity. Preferred dimensions for the spreader layer 205 are about one inch in diameter and about 0.010 of an inch thick. FIG. 3 shows a preferred embodiment of the spreader layer 205 with a beveled edge. Although not required, an approximate 45° bevel is preferred. - A protective layer201 is formed on the top surface of the spreader layer 205. The protective layer is intended to protect the top surface of the spreader layer 205 from damage. Ideally, the protective layer is highly resistant to mechanical damage, such as scratching and other abrasive forces. Additionally, the protective layer is infrared transmissive. It is particularly advantageous if the protective layer 201 is also optimized to have antireflective properties and to increase transmission of optical radiation in the wavelength range of about 5 to 12μ. For example, when a float zone silicon is used as a spreader layer 205, the spreader layer reflects 30% of the incident light at the air:silicon interface because of the relatively high refractive index of silicon. The protective layer 201 is designed to match the refractive index of tissue and reduce the surface reflectance of the spreader layer 205, thereby optimizing the amount of energy passing through the
window assembly 200. The protective layer 201 must also have high thermal conductivity. A satisfactory protective layer material is a proprietary multi-layer Broad Band Anti-Reflective Coating produced by Deposition Research Laboratories, Inc. of St. Charles, Mo. Diamondlike carbon coatings are also satisfactory. - Underlying the spreader layer205 is a
heating element 220. Theheating element 220 must also provide a maximum acceptable optical throughput and should be electrically insulated from the spreader layer substrate material. Apreferred heating element 220 obscures about 10% or less of thewindow assembly 200. Satisfactory heating elements include, but are not limited to, heat exchangers, electrical resistance heating grids, thermal electric heaters, radio frequency (RF) heaters, infrared radiation heaters, optical heaters, or wire bridge heating grids. Additionally, a doped infrared transmissive material with regions of higher and lower resistivity may be used. For example, a doped silicon layer may be used as a heater. - One embodiment of such a
heater element 220 is the heating grid shown in FIG. 4. The embodiment shown in FIG. 4 shows ametal heater grid 221 designed and manufactured by Deposition Research Laboratories, Inc. Theheater grid 221 has a resistance of about 2 ohms and has a preferred thickness of 1,500 Å. A preferred grid material is a gold alloy, but other acceptable materials include, but are not limited to, platinum (Pt), titanium (Ti), tungsten (W), copper (Cu), and nickel (Ni). The perimeter of the grid is surrounded by abus bar 222 for contacting electrode leads. Theheater 220 is covered with an electrically insulating coating which also enhances adhesion to the spreader layer 205. One preferred covering is an aluminum oxide (Al2O3) coating over the grid pattern to prevent electrical current from conducting through the spreader layer 205 into thetissue 100. Al2O3 also advantageously increases the adhesion of theheater element 220 to the spreader layer 205. Other acceptable materials include, but are not limited to, titanium dioxide (TiO2) or zinc selenide (ZnSe). Theheater grid 221 is electrically connected to an electrical power source through thebus 222. A preferred bus bar material is gold. One preferred example of a heater grid incorporates a variable pitch distance “d” between the conducting lines to maintain a constant power density across theentire grid 221. In this embodiment a preferred line width “w” is about 25 microns. Another design for maintaining a constant power density across theentire grid 221 incorporates varying line widths “w” while keeping the pitch distance “d” constant. - Referring again to FIGS. 2 and 3, underlying the
heater 220 is a thermal insulating layer 230. The thermal insulating layer 230 serves several novel and surprising functions which will be discussed in more detail below. The thermal insulating layer 230 prevents the dissipation of heat from theheater element 220 while allowing the cold from a cooling element (not shown) to effectively cool thetissue 100. The thermal insulating layer 230 is comprised of a material having thermally insulative (e.g., lower thermal conductivity than the spreader layer) and infrared transmissive qualities. A preferred material is a germanium arsenic selenium compound of the calcogenide glass family known as AMTIR-1 produced by Amorphous Materials, Inc. of Garland, Tex. A further description of this material may be found on that firm's material data safety sheet (MSDS). The pictured embodiment has a diameter of about 0.85 of an inch and a preferred thickness in the range of about 0.005 to about 0.010 of an inch. As theheating element 220 heats through the spreader layer 205 into thetissue 100, the thermal insulating layer 230 (having a low thermal conductivity) insulates this heat. Underlying the thermal insulating layer 230 is a base layer 240 which is formed of thermally conducting material. A preferred material is crystalline silicon formed using float zone crystal growth. The purpose of this base layer 240 is to serve as a cold-conducting mechanical base for the entire layered window assembly. The bottom surface of the base layer is treated with an overcoat layer 242. The overcoat layer 242 is preferably a proprietary multi-layer Broad Band Anti-Reflective Coating optimized for the transmission of radiation in the wavelength range between about 5 to about 12μ and having the refractive index of air. Such coating materials are available from Deposition Research Laboratories, Inc. in St. Charles, Mo. - The overall optical transmission of the layered
window assembly 200 is equal to or greater than 70%. Thelayered window assembly 200 is held together and secured to thegradient device 500 by a holding bracket. The bracket is preferably formed of a glass-filled plastic, for example, Ultem 2300, manufactured by General Electric. The Ultem 2300 has a low thermal conductivity which insulates the heat transfer from the layeredwindow assembly 200. As such, thetissue 100 is solely heated and cooled by the heat and cold emanating from the layeredwindow assembly 200. - Referring to FIG. 5, a portion of the entire solid-state non-invasive device for determining analyte concentration in sample tissues is shown. The
layered window assembly 200 is depicted as resting above acold reservoir 330 which is adjacent to thecooling element 350. Thecooling element 350 may be selected from such elements as air cooled convection coolers, passive conduction coolers, such as heat sinks, or active conduction coolers, such as, thermal electric coolers. Thecooling element 350 may be also selected from the group of cooling elements including, but not limited to, water baths, gas coolers using cold N2 or other gases, or infrared transmissive cooling fluids. The preferred cooling element is a thermal electric cooler, for example, a 25 W thermal electric cooler manufactured by Melcor in Trenton, N.J. The cooling element 350 (hereinafter referred to as “thermal electric cooler” or “TEC”) is positioned in thermal contact with thecold reservoir 330. A preferredcold reservoir 330 is a copper ring structure which is in thermal contact with both thelayered window assembly 220 and theTEC 350. - It is the combination of the
heating element 220, the thermal insulating element 230, thecold reservoir 330, and thecooling element 350 that comprises a means for inducing a temperature gradient in thetissue 100. Typically, this is accomplished by setting thecooling element 350 to a constant temperature of in the range of about 8-15° C. Theheating element 220 is then cyclically activated to heat to a maximum of about 40° C. Thermal cycling theheating element 220 cyclically heats the layeredwindow assembly 200 and induces a temperature gradient in thetissue 100. - With continuing reference to FIG. 5, the inventors discovered that when a thermal electric cooler is chosen as the
cooling element 350, a certain amount of waste heat builds up in thegradient device 500. In order to stabilize the operational temperature of the device, aheat sink 400 is in thermal communication with theTEC 350. Theheat sink 400 effectively bleeds off the waste heat from theTEC 350, enabling thedevice 500 to function within a constant temperature range. Furthermore, the heat sink may have coolingfins 410 to enhance the cooling effectiveness of theheat sink 400. Additionally, theheat sink 400 features acavity 420. The cavity may be filled with a phase change material 430 (not shown) to enhance the temperature stabilizing effect of theheat sink 400. A phase change material 430 as defined herein is any material which undergoes a temperature dependent change of phase. For example, water undergoes a phase change from ice to water. In the process of undergoing the phase change, such materials absorb a great deal of heat, thereby enhancing the effectiveness of theheat sink 400. A preferred phase change material 430 is a hydrated salt, such as calcium chloride hexahydrate. A proprietary version of this material, TH29, is produced by Phase Change Solutions, of Naperville, Ill. Further description of this material is included in that firm's MSDS which is incorporated by reference. This material has a melting point of 29° C., which is close to the working temperature of the device. The effectiveness of this phase change material 430 is clearly demonstrated in FIG. 6, which is a graph of temperature stability over time with the instrument operating normally. The temperature stability, over time, of a heat sink using TH29 610 has superior temperature stability performance than both water 620 and aheat sink 400 with no phase change material 630. - The ability of the gradient inducing means is further enhanced by the presence of the thermal insulating layer230 of the layered
window assembly 200. The thermal insulating layer 230 is positioned between theheating element 220 and the base 240. It was discovered by the inventors that, in the absence of the insulating element 230, the cold from thecooling element 350 excessively reduced the temperature of theheating element 220. This led to difficulties in reheating. In order to sufficiently rewarm theheating element 220 after such cooling, a great deal of power was required. Furthermore, the time required to heat thecooling element 350 to operational temperature prohibitively restricted the cycle time. Therefore, in an effort to increase the rate of heating and cooling and increase cycle time, a thermally insulating element 230 was added. The presence of the insulating element 230 helps theheating element 220 to maintain a consistent and relatively high temperature, thereby making it possible to reheat theheating element 220 and spreader layer 205 and, consequently, thetissue 100 more quickly. Of equal importance the insulating element makes reheating possible using less power. These factors make quicker cycle times possible. The surprising result is that the presence of the insulating layer 230 does not significantly inhibit the cooling effects of theTEC 350. Therefore, the gradient inducing means (i.e. theheating element 220, the thermally insulating element 230, and the cooling element 350) are substantially enhanced in their effectiveness by the presence of the thermally insulating layer 230. - The layered
window assembly 200 is designed with the idea of transmitting the maximum amount of optical energy through thewindow 200. Furthermore, thecold reservoir 330, thethermal cooling element 350, andheat sink 400 are all designed to minimally obstruct the transmission of optical radiation. Positioned beneath the layeredwindow assembly 200 is an infraredradiation detector assembly 700. - With reference to FIGS. 5 and 7, a particular embodiment of the
infrared radiation detector 720, which forms a part of the infraredradiation detector assembly 700, is shown. It should be pointed out that many different types of radiation detectors may be utilized including, but not limited to, interferometers, spectrophotometers, grating monochromators, variable filter monochromators, and groups of discrete infrared bandpass filters (or Fabry-Perot filters, including tunable Fabry-Perot filters) and detectors. The effectiveness of said infraredradiation detector assembly 700 may be enhanced by the presence of ahigh reflectance scrambler 710. Thescrambler 710 is designed to randomize the directionality of radiation which enters the layeredwindow assembly 200. Thescrambler 710 effectively minimizes the effect of tissue irregularities thereby maximizing the detectable signal. Thescrambler 710 is either made from, or coated with, a material which does not preferentially absorb optical radiation in the range of about 5μ to about 12μ. Asatisfactory scrambler 710 may be constructed having an electroform gold layer. A satisfactory high reflectivity gold electroformoptical scrambler 710 is manufactured by Epner Technology, of Brooklyn, N.Y. At the exit of thescrambler 712 lies adetector element 720. As explained above, thedetector element 720 may be selected from among many suitable devices. One preferred embodiment uses a series ofbandpass filters 720F having an underlying series ofradiation detectors 720D. - One embodiment uses several bandpass wavelengths optimized to detect the presence of a glucose analyte in a tissue sample. Glucose has several strong and distinguishing absorption peaks between 9 and 10 microns; meaning the transmission of optical energy through glucose drops significantly in this wavelength range. As the infrared energy naturally emitted by the inner tissue passes through the glucose in the outer layers of the tissue, some of the energy in the 9.3 micron and 9.6 micron bands is absorbed.
- At these particular wavelengths where glucose absorbs strongly, more energy originating deep within the tissue is absorbed before it reaches the surface. At other wavelengths where glucose is only weakly absorbent, a larger amount of energy from deep within the tissue finds its way to the surface. Additionally, at wavelength ranges where glucose doesn't absorb, for example about 8-9 microns, a reference signal which may be used for the differentiation of glucose, may be measured. Thus, the large magnitude and specificity of the glucose absorption peaks allows the differentiation of glucose from other interfering substances.
- Because the human body is comprised mostly of water, it is necessary to differentiate the smaller amount of glucose present in the larger concentration of water in the human body. Water absorbs far- and mid-wavelength infrared energy at most wavelengths. However, an infrared transmission “window” exists in water, in which infrared energy is not completely absorbed. This “window” allows analysis of the 9.3 and 9.6 micron glucose absorption bands because this region of substantially reduced water absorption is the same region in which glucose strongly absorbs. Also, more specifically, in the wavelength range of about 10-11 microns, neither water nor biological substances absorb strongly. Therefore, this wavelength range may also provide reference wavelengths for both water and glucose, allowing their quantification.
- On the other hand, the wavelength ranges where water strongly absorbs can be used to determine the absorbance of the target tissue and, therefore, the surface radiation. For example, wavelengths in the range of about 5.9-6.2 microns, may be used to quantify water. Additionally, in the range of about 11.5-13 microns, strong and distinct water absorption peaks exist, providing ideal wavelengths for analyzing the tissue surface temperature.
- Other wavelength ranges can be examined. They enhance the ability of the device to differentiate non-water, non-glucose effects in the tissue. For example, radiation has maximum tissue penetration in the 5.0-5.5 wavelength range. Therefore, information about the maximum analytical tissue depth can be obtained in this range where neither H2O nor biological constituents absorb. Some proteins and some glycosylated proteins are examples of a significant class of interfering substances which interfere with the accurate measurement of glucose in blood. Because proteins have major absorption peaks about the (6.2-6.6), (7.9-8.1), and (9-10) micron wavelength ranges, they can be isolated and compensated for. In addition, an appropriate reference signal for protein can be measured outside of these ranges, for example, at about 8.2 or 8.3 microns.
- Different filter combinations can be optimized to detect other interfering analytes as well. In addition to proteins, other materials may be compensated for. Examples of other interfering substances include, but are not limited to, Vitamin C, acetaminophen, alcohol, and urea.
- One preferred embodiment, optimized to detect the presence of a glucose analyte in a tissue sample, uses eight
filters 720F having the following bandpass center wavelengths: 6.1μ, 6.9μ, 8.5μ, 9.3μ, 9.7μ, 10.4μ, 11.0μ, and 12.5μ. Filter combinations using a greater or a fewer number or different filters may be used. Satisfactory filters may be obtained from Optical Coating Laboratory, Inc. (OCLI) of Santa Rosa, Calif. It is contemplated that in accordance with the principles of the present invention, other filters or filter combinations optimized to detect other analytes may be used. Also, other detection methods or devices are contemplated by the present invention. The filtered radiation can be detected by a plurality ofdetectors 720D, for example, an array of Photo Voltiac Mercury Cadmium Tellerium (PVMCT) detectors. Satisfactory detectors may be obtained from FERMIONICS of Simi Valley, Calif., for example, PV-9.1 detectors with PVA-481-1 preamplifiers may be used. Additionally, room temperature micro-bolometers can be used. These detectors produce an electronic signal which is passed on to asignal processing system 800. Custom circuit boards produced by Optiscan may be used to control temperatures of the detector and the infrared transmissive window assembly. Similar units available from other manufacturers may also be used. - A satisfactory
signal processing system 800 is a general purpose programmable personal computer commonly available from companies such as an IBM, Dell, Gateway, etc. Numerous other computers or data processing devices may be used with equal facility. Furthermore, a specialized computer, implemented as hardware, firmware, software or a combination thereof could be devised to accomplish the needed signal processing functions. The computer provides a computational engine, display and user interface. An analog-to-digital (A/D) system may be used to convert analog detector signals to appropriate computer input signals. For example, an acceptable A/D converter is a “PCI-MIO-16XE10” manufactured by National Instruments of Austin, Tex. - It will be appreciated that many modifications can be made to the embodiments described above without departing from the spirit and the scope of the invention.
- In particular, it should be noted that many different phase change materials may be used in conjunction with the heat sink as can many different layered window assemblies. Also, if bandpass filters are used in conjunction with the infrared detector, many different filters may be used and said filters may be optimized to detect analytes other than glucose.
- The present invention has been particularly shown and described with respect to certain preferred embodiments and the features thereof. It is to be understood that the shown embodiments are the presently preferred embodiments of the present invention and, as such, are representative of the subject matter broadly contemplated by the present invention. The scope of the invention fully encompasses other embodiments which may become obvious to those skilled in the art, and are accordingly to be limited by nothing other than the appended claims, in which reference to an element in the singular is not intended to mean “one and only one” unless explicitly stated, but rather “one or more”. All structural and functional equivalents of the elements of the above-described preferred embodiments that are known or later come to be known to those of ordinary skill in the art are expressly incorporated herein by reference and are intended to be encompassed by the present claims. Moreover, it is not necessary for a device or method to address each and every problem solved by the present invention, for it to be encompassed by the present claims. Furthermore, no element, component, or method step in the present disclosure is intended to be depicted to the public regardless of whether the element, component, or method step is explicitly recited in the claims. No claim element herein is to be construed under the provisions of 35 U.S.C. § 112, paragraph 6, unless the element is expressly recited using the phrase “means for”.
Claims (81)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/684,857 US20040138537A1 (en) | 1999-03-10 | 2003-10-14 | Solid-state non-invasive thermal cycling spectrometer |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/265,195 US6198949B1 (en) | 1999-03-10 | 1999-03-10 | Solid-state non-invasive infrared absorption spectrometer for the generation and capture of thermal gradient spectra from living tissue |
US09/427,178 US6633771B1 (en) | 1999-03-10 | 1999-10-25 | Solid-state non-invasive thermal cycling spectrometer |
US10/684,857 US20040138537A1 (en) | 1999-03-10 | 2003-10-14 | Solid-state non-invasive thermal cycling spectrometer |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/427,178 Continuation US6633771B1 (en) | 1999-03-10 | 1999-10-25 | Solid-state non-invasive thermal cycling spectrometer |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040138537A1 true US20040138537A1 (en) | 2004-07-15 |
Family
ID=23693798
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/427,178 Expired - Fee Related US6633771B1 (en) | 1999-03-10 | 1999-10-25 | Solid-state non-invasive thermal cycling spectrometer |
US10/684,857 Abandoned US20040138537A1 (en) | 1999-03-10 | 2003-10-14 | Solid-state non-invasive thermal cycling spectrometer |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/427,178 Expired - Fee Related US6633771B1 (en) | 1999-03-10 | 1999-10-25 | Solid-state non-invasive thermal cycling spectrometer |
Country Status (6)
Country | Link |
---|---|
US (2) | US6633771B1 (en) |
EP (1) | EP1223857A4 (en) |
JP (1) | JP2004500163A (en) |
AU (1) | AU1249401A (en) |
CA (1) | CA2385288A1 (en) |
WO (1) | WO2001030236A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070093748A1 (en) * | 2005-06-23 | 2007-04-26 | Medtronic Vascular, Inc. | Methods and systems for treating injured cardiac tissue |
US20070172472A1 (en) * | 2005-06-23 | 2007-07-26 | Asha Nayak | Methods and Systems for Treating Injured Cardiac Tissue |
WO2023059634A1 (en) * | 2021-10-05 | 2023-04-13 | Materion Corporation | Window cavity wafers |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6959211B2 (en) | 1999-03-10 | 2005-10-25 | Optiscan Biomedical Corp. | Device for capturing thermal spectra from tissue |
US6631282B2 (en) | 2001-08-09 | 2003-10-07 | Optiscan Biomedical Corporation | Device for isolating regions of living tissue |
AU2002353914A1 (en) * | 2001-10-29 | 2003-05-12 | Optiscan Biomedical Corporation | Window assembly for thermal gradient spectrometer |
US7050157B2 (en) * | 2001-11-08 | 2006-05-23 | Optiscan Biomedical Corp. | Reagent-less whole-blood glucose meter |
US6731961B2 (en) | 2001-11-09 | 2004-05-04 | Optiscan Biomedical Corp. | Method for transforming phase spectra to absorption spectra |
US6917038B2 (en) | 2001-11-21 | 2005-07-12 | Optiscan Biomedical Corporation | Method and apparatus for adjusting signal variation of an electronically controlled infrared transmissive window |
WO2003045235A1 (en) | 2001-11-21 | 2003-06-05 | Optiscan Biomedical Corporation | Method for adjusting a blood analyte measurement |
US6862534B2 (en) | 2001-12-14 | 2005-03-01 | Optiscan Biomedical Corporation | Method of determining an analyte concentration in a sample from an absorption spectrum |
US7009180B2 (en) * | 2001-12-14 | 2006-03-07 | Optiscan Biomedical Corp. | Pathlength-independent methods for optically determining material composition |
EP1528890A1 (en) | 2002-08-14 | 2005-05-11 | Optiscan Biomedical Corporation | Device and method for in vitro determination of analyte concentrations within body fluids |
US20040132171A1 (en) * | 2003-01-06 | 2004-07-08 | Peter Rule | Wearable device for measuring analyte concentration |
US7271912B2 (en) | 2003-04-15 | 2007-09-18 | Optiscan Biomedical Corporation | Method of determining analyte concentration in a sample using infrared transmission data |
US7075652B1 (en) | 2004-11-12 | 2006-07-11 | Ibet, Inc. | Apparatus and method for measuring temperature dependent properties of liquid |
US20080221411A1 (en) * | 2007-03-09 | 2008-09-11 | Nellcor Puritan Bennett Llc | System and method for tissue hydration estimation |
US20110004080A1 (en) * | 2008-04-11 | 2011-01-06 | Glucovista, Llc | Method for non-invasive analysis of a substance concentration within a body |
US20110230942A1 (en) * | 2008-12-01 | 2011-09-22 | The Johns Hopkins University | High-resolution infrared imaging for enhanced detection, diagnosis, and treatment of cutaneous lesions |
US10475529B2 (en) | 2011-07-19 | 2019-11-12 | Optiscan Biomedical Corporation | Method and apparatus for analyte measurements using calibration sets |
US8466425B2 (en) * | 2011-09-29 | 2013-06-18 | Boise State University | Chalcogenide glass ionizing radiation sensor |
EP3157428B1 (en) * | 2014-06-19 | 2019-09-25 | GlucoVista Inc. | Substance concentration monitoring apparatuses and methods |
KR20200043184A (en) * | 2018-10-17 | 2020-04-27 | 삼성전자주식회사 | Apparatus and method for processing spectrum according to change of object temperature |
US11020014B2 (en) * | 2018-11-30 | 2021-06-01 | Microsoft Technology Licensing, Llc | Photoplethysmogram device with skin temperature regulator |
US20230059061A1 (en) | 2020-02-28 | 2023-02-23 | Sony Group Corporation | Biological information acquisition device, biological information acquisition system, and biological information acquisition method |
Citations (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3628525A (en) * | 1969-06-19 | 1971-12-21 | American Optical Corp | Blood oxygenation and pulse rate monitoring apparatus |
US3703639A (en) * | 1969-11-12 | 1972-11-21 | Sybron Corp | Radiation moisture measuring system having thermoelectrically cooled detector |
US3770958A (en) * | 1972-01-05 | 1973-11-06 | Honeywell Inc | Infrared radiation detection by a matched system |
US3950560A (en) * | 1974-06-14 | 1976-04-13 | The United States Of America As Represented By The Secretary Of The Army | Method of producing compacted, dehydrated, vegetable products of increased density |
US4259963A (en) * | 1979-07-03 | 1981-04-07 | Albert Huch | Multi-purpose transducer for transcutaneous blood measurements |
US4655225A (en) * | 1985-04-18 | 1987-04-07 | Kurabo Industries Ltd. | Spectrophotometric method and apparatus for the non-invasive |
US4890619A (en) * | 1986-04-15 | 1990-01-02 | Hatschek Rudolf A | System for the measurement of the content of a gas in blood, in particular the oxygen saturation of blood |
US5007423A (en) * | 1989-10-04 | 1991-04-16 | Nippon Colin Company Ltd. | Oximeter sensor temperature control |
US5009230A (en) * | 1988-05-31 | 1991-04-23 | Eol, Inc. | Personal glucose monitor |
US5070242A (en) * | 1989-01-13 | 1991-12-03 | Iowa State University Research Foundation, Inc. | Apparatus and method for transient thermal infrared spectrometry |
US5092342A (en) * | 1989-06-10 | 1992-03-03 | Dragerwerk Aktiengesellschaft | Sensor arrangement for optically measuring gas components |
US5131391A (en) * | 1989-06-22 | 1992-07-21 | Colin Electronics Co., Ltd. | Pulse oxymeter having probe with warming means |
US5137023A (en) * | 1990-04-19 | 1992-08-11 | Worcester Polytechnic Institute | Method and apparatus for monitoring blood analytes noninvasively by pulsatile photoplethysmography |
US5191215A (en) * | 1989-01-13 | 1993-03-02 | Iowa State University Research Foundation, Inc. | Apparatus and method for transient thermal infrared spectrometry of flowable enclosed materials |
US5281817A (en) * | 1989-09-01 | 1994-01-25 | Critikon, Inc. | Method of selecting an optical filter for a shutterless optically stabilized capnograph |
US5291022A (en) * | 1992-07-01 | 1994-03-01 | Nicolet Instrument Corporation | High efficiency infrared source |
US5313941A (en) * | 1993-01-28 | 1994-05-24 | Braig James R | Noninvasive pulsed infrared spectrophotometer |
US5362966A (en) * | 1990-06-27 | 1994-11-08 | Rosenthal Robert D | Measurement of finger temperature in near-infrared quantitative measurement instrument |
US5379764A (en) * | 1992-12-09 | 1995-01-10 | Diasense, Inc. | Non-invasive determination of analyte concentration in body of mammals |
US5515847A (en) * | 1993-01-28 | 1996-05-14 | Optiscan, Inc. | Self-emission noninvasive infrared spectrophotometer |
US5601079A (en) * | 1992-03-12 | 1997-02-11 | Wong; Jacob Y. | Non-invasive quantification of glucose control, aging, and advanced maillard products by stimulated fluorescence |
US5615672A (en) * | 1993-01-28 | 1997-04-01 | Optiscan, Inc. | Self-emission noninvasive infrared spectrophotometer with body temperature compensation |
US5657754A (en) * | 1995-07-10 | 1997-08-19 | Rosencwaig; Allan | Apparatus for non-invasive analyses of biological compounds |
US5750994A (en) * | 1995-07-31 | 1998-05-12 | Instrumentation Metrics, Inc. | Positive correlation filter systems and methods of use thereof |
US5795305A (en) * | 1993-12-12 | 1998-08-18 | Ok-Kyung Cho | Process and device for non-invasive determination of glucose concentration in parts of the human body |
US5900632A (en) * | 1997-03-12 | 1999-05-04 | Optiscan Biomedical Corporation | Subsurface thermal gradient spectrometry |
US6002953A (en) * | 1998-05-06 | 1999-12-14 | Optix Lp | Non-invasive IR transmission measurement of analyte in the tympanic membrane |
US6025597A (en) * | 1995-10-17 | 2000-02-15 | Optiscan Biomedical Corporation | Non-invasive infrared absorption spectrometer for measuring glucose or other constituents in a human or other body |
US6070093A (en) * | 1997-12-02 | 2000-05-30 | Abbott Laboratories | Multiplex sensor and method of use |
US6072180A (en) * | 1995-10-17 | 2000-06-06 | Optiscan Biomedical Corporation | Non-invasive infrared absorption spectrometer for the generation and capture of thermal gradient spectra from living tissue |
US6161028A (en) * | 1999-03-10 | 2000-12-12 | Optiscan Biomedical Corporation | Method for determining analyte concentration using periodic temperature modulation and phase detection |
US6198949B1 (en) * | 1999-03-10 | 2001-03-06 | Optiscan Biomedical Corporation | Solid-state non-invasive infrared absorption spectrometer for the generation and capture of thermal gradient spectra from living tissue |
US6196046B1 (en) * | 1999-08-25 | 2001-03-06 | Optiscan Biomedical Corporation | Devices and methods for calibration of a thermal gradient spectrometer |
US6241663B1 (en) * | 1998-05-18 | 2001-06-05 | Abbott Laboratories | Method for improving non-invasive determination of the concentration of analytes in a biological sample |
US20020026106A1 (en) * | 1998-05-18 | 2002-02-28 | Abbots Laboratories | Non-invasive sensor having controllable temperature feature |
US6353226B1 (en) * | 1998-11-23 | 2002-03-05 | Abbott Laboratories | Non-invasive sensor capable of determining optical parameters in a sample having multiple layers |
US20020028080A1 (en) * | 2000-09-01 | 2002-03-07 | Yoshikazu Naito | Recycle information system and image forming apparatus for recycling |
US6526298B1 (en) * | 1998-05-18 | 2003-02-25 | Abbott Laboratories | Method for the non-invasive determination of analytes in a selected volume of tissue |
-
1999
- 1999-10-25 US US09/427,178 patent/US6633771B1/en not_active Expired - Fee Related
-
2000
- 2000-08-30 WO PCT/US2000/040785 patent/WO2001030236A1/en not_active Application Discontinuation
- 2000-08-30 CA CA002385288A patent/CA2385288A1/en not_active Abandoned
- 2000-08-30 AU AU12494/01A patent/AU1249401A/en not_active Abandoned
- 2000-08-30 EP EP00974066A patent/EP1223857A4/en not_active Withdrawn
- 2000-08-30 JP JP2001532659A patent/JP2004500163A/en active Pending
-
2003
- 2003-10-14 US US10/684,857 patent/US20040138537A1/en not_active Abandoned
Patent Citations (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3628525A (en) * | 1969-06-19 | 1971-12-21 | American Optical Corp | Blood oxygenation and pulse rate monitoring apparatus |
US3703639A (en) * | 1969-11-12 | 1972-11-21 | Sybron Corp | Radiation moisture measuring system having thermoelectrically cooled detector |
US3770958A (en) * | 1972-01-05 | 1973-11-06 | Honeywell Inc | Infrared radiation detection by a matched system |
US3950560A (en) * | 1974-06-14 | 1976-04-13 | The United States Of America As Represented By The Secretary Of The Army | Method of producing compacted, dehydrated, vegetable products of increased density |
US4259963A (en) * | 1979-07-03 | 1981-04-07 | Albert Huch | Multi-purpose transducer for transcutaneous blood measurements |
US4655225A (en) * | 1985-04-18 | 1987-04-07 | Kurabo Industries Ltd. | Spectrophotometric method and apparatus for the non-invasive |
US4890619A (en) * | 1986-04-15 | 1990-01-02 | Hatschek Rudolf A | System for the measurement of the content of a gas in blood, in particular the oxygen saturation of blood |
US5009230A (en) * | 1988-05-31 | 1991-04-23 | Eol, Inc. | Personal glucose monitor |
US5075552A (en) * | 1989-01-13 | 1991-12-24 | Iowa State University Research Foundation Inc. | Apparatus and method for transient thermal infrared emission spectrometry |
US5070242A (en) * | 1989-01-13 | 1991-12-03 | Iowa State University Research Foundation, Inc. | Apparatus and method for transient thermal infrared spectrometry |
US5191215A (en) * | 1989-01-13 | 1993-03-02 | Iowa State University Research Foundation, Inc. | Apparatus and method for transient thermal infrared spectrometry of flowable enclosed materials |
US5092342A (en) * | 1989-06-10 | 1992-03-03 | Dragerwerk Aktiengesellschaft | Sensor arrangement for optically measuring gas components |
US5131391A (en) * | 1989-06-22 | 1992-07-21 | Colin Electronics Co., Ltd. | Pulse oxymeter having probe with warming means |
US5281817A (en) * | 1989-09-01 | 1994-01-25 | Critikon, Inc. | Method of selecting an optical filter for a shutterless optically stabilized capnograph |
US5007423A (en) * | 1989-10-04 | 1991-04-16 | Nippon Colin Company Ltd. | Oximeter sensor temperature control |
US5137023A (en) * | 1990-04-19 | 1992-08-11 | Worcester Polytechnic Institute | Method and apparatus for monitoring blood analytes noninvasively by pulsatile photoplethysmography |
US5362966A (en) * | 1990-06-27 | 1994-11-08 | Rosenthal Robert D | Measurement of finger temperature in near-infrared quantitative measurement instrument |
US5601079A (en) * | 1992-03-12 | 1997-02-11 | Wong; Jacob Y. | Non-invasive quantification of glucose control, aging, and advanced maillard products by stimulated fluorescence |
US5291022A (en) * | 1992-07-01 | 1994-03-01 | Nicolet Instrument Corporation | High efficiency infrared source |
US5379764A (en) * | 1992-12-09 | 1995-01-10 | Diasense, Inc. | Non-invasive determination of analyte concentration in body of mammals |
US5515847A (en) * | 1993-01-28 | 1996-05-14 | Optiscan, Inc. | Self-emission noninvasive infrared spectrophotometer |
US5313941A (en) * | 1993-01-28 | 1994-05-24 | Braig James R | Noninvasive pulsed infrared spectrophotometer |
US5615672A (en) * | 1993-01-28 | 1997-04-01 | Optiscan, Inc. | Self-emission noninvasive infrared spectrophotometer with body temperature compensation |
US5795305A (en) * | 1993-12-12 | 1998-08-18 | Ok-Kyung Cho | Process and device for non-invasive determination of glucose concentration in parts of the human body |
US5657754A (en) * | 1995-07-10 | 1997-08-19 | Rosencwaig; Allan | Apparatus for non-invasive analyses of biological compounds |
US5750994A (en) * | 1995-07-31 | 1998-05-12 | Instrumentation Metrics, Inc. | Positive correlation filter systems and methods of use thereof |
US6072180A (en) * | 1995-10-17 | 2000-06-06 | Optiscan Biomedical Corporation | Non-invasive infrared absorption spectrometer for the generation and capture of thermal gradient spectra from living tissue |
US6025597A (en) * | 1995-10-17 | 2000-02-15 | Optiscan Biomedical Corporation | Non-invasive infrared absorption spectrometer for measuring glucose or other constituents in a human or other body |
US5900632A (en) * | 1997-03-12 | 1999-05-04 | Optiscan Biomedical Corporation | Subsurface thermal gradient spectrometry |
US6070093A (en) * | 1997-12-02 | 2000-05-30 | Abbott Laboratories | Multiplex sensor and method of use |
US6002953A (en) * | 1998-05-06 | 1999-12-14 | Optix Lp | Non-invasive IR transmission measurement of analyte in the tympanic membrane |
US20020026106A1 (en) * | 1998-05-18 | 2002-02-28 | Abbots Laboratories | Non-invasive sensor having controllable temperature feature |
US6526298B1 (en) * | 1998-05-18 | 2003-02-25 | Abbott Laboratories | Method for the non-invasive determination of analytes in a selected volume of tissue |
US20020055671A1 (en) * | 1998-05-18 | 2002-05-09 | Xiaomao Wu | Method for improving non-invasive determination of the concentration of analytes in a biological sample |
US6241663B1 (en) * | 1998-05-18 | 2001-06-05 | Abbott Laboratories | Method for improving non-invasive determination of the concentration of analytes in a biological sample |
US6353226B1 (en) * | 1998-11-23 | 2002-03-05 | Abbott Laboratories | Non-invasive sensor capable of determining optical parameters in a sample having multiple layers |
US6198949B1 (en) * | 1999-03-10 | 2001-03-06 | Optiscan Biomedical Corporation | Solid-state non-invasive infrared absorption spectrometer for the generation and capture of thermal gradient spectra from living tissue |
US6161028A (en) * | 1999-03-10 | 2000-12-12 | Optiscan Biomedical Corporation | Method for determining analyte concentration using periodic temperature modulation and phase detection |
US6580934B1 (en) * | 1999-03-10 | 2003-06-17 | Optiscan Biomedical Corporation | Method and apparatus for determining analyte concentration using phase and magnitude detection of a radiation transfer function |
US6196046B1 (en) * | 1999-08-25 | 2001-03-06 | Optiscan Biomedical Corporation | Devices and methods for calibration of a thermal gradient spectrometer |
US20020028080A1 (en) * | 2000-09-01 | 2002-03-07 | Yoshikazu Naito | Recycle information system and image forming apparatus for recycling |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070093748A1 (en) * | 2005-06-23 | 2007-04-26 | Medtronic Vascular, Inc. | Methods and systems for treating injured cardiac tissue |
US20070172472A1 (en) * | 2005-06-23 | 2007-07-26 | Asha Nayak | Methods and Systems for Treating Injured Cardiac Tissue |
WO2023059634A1 (en) * | 2021-10-05 | 2023-04-13 | Materion Corporation | Window cavity wafers |
Also Published As
Publication number | Publication date |
---|---|
AU1249401A (en) | 2001-05-08 |
EP1223857A1 (en) | 2002-07-24 |
EP1223857A4 (en) | 2003-06-25 |
US6633771B1 (en) | 2003-10-14 |
JP2004500163A (en) | 2004-01-08 |
WO2001030236A1 (en) | 2001-05-03 |
CA2385288A1 (en) | 2001-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6633771B1 (en) | Solid-state non-invasive thermal cycling spectrometer | |
US6825044B2 (en) | Method for adjusting a blood analyte measurement | |
US6636753B1 (en) | Solid-state non-invasive infrared absorption spectrometer for the generation and capture of thermal gradient spectra form living tissue | |
US7009180B2 (en) | Pathlength-independent methods for optically determining material composition | |
US6931328B2 (en) | Analyte detection system with software download capabilities | |
US6771993B2 (en) | Sample adapter | |
US20030133118A1 (en) | Method for transforming phase spectra to absorption spectra | |
US7050157B2 (en) | Reagent-less whole-blood glucose meter | |
US20030108976A1 (en) | Method and apparatus for improving clinical accuracy of analyte measurements | |
US20040132171A1 (en) | Wearable device for measuring analyte concentration | |
WO2004062494A1 (en) | Sample element for reagentless whole blood glucose meter | |
US6917038B2 (en) | Method and apparatus for adjusting signal variation of an electronically controlled infrared transmissive window | |
US20030122081A1 (en) | Window assembly | |
AU2002359713B2 (en) | Spectroscopic method of determining an analyte concentration in a sample | |
EP1850114A1 (en) | Spectroscopic method of determining an analyte concentration in a sample | |
US20030215939A1 (en) | Active sample collection system for analyte detection apparatus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: HERCULES TECHNOLOGY II, L.P., CALIFORNIA Free format text: SECURITY AGREEMENT;ASSIGNOR:OPTISCAN BIOMEDICAL CORPORATION;REEL/FRAME:020995/0202 Effective date: 20080522 Owner name: HERCULES TECHNOLOGY II, L.P.,CALIFORNIA Free format text: SECURITY AGREEMENT;ASSIGNOR:OPTISCAN BIOMEDICAL CORPORATION;REEL/FRAME:020995/0202 Effective date: 20080522 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: OPTISCAN BIOMEDICAL CORPORATION, CALIFORNIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:HERCULES TECHNOLOGY II, L.P.;REEL/FRAME:041344/0534 Effective date: 20170111 |